首页>
外国专利>
Modified release Tablets containing amoxicillin and clavulanate potassium
Modified release Tablets containing amoxicillin and clavulanate potassium
展开▼
机译:含阿莫西林和克拉维酸钾的缓释片
展开▼
页面导航
摘要
著录项
相似文献
摘要
As a result, the government provided 1900-2600 mg of amoxicillin and a large amount of potassium butyrate, so the ratio between the two components was 2:1-20:1,Every 12 hours and 1 minute, a modified drug release formula, including amoxicillin and potassium butyrate, in the proportion of 2:1 to 20:1, wherein all the formulas of potassium butyrate and the first part of amoxicillin are precursor chemicals acceptable on drugs, allowing immediate release 2. In order to form a direct release phase, amitriptyline, potassium nailing and amitriptyline made of amitriptyline and amoxicillin in the first part, and amoxicillin in the second part made of a pharmaceutically acceptable prosthetic, allowing slow release of amitriptyline in the second part;In order to form a slow release phase, the drug formulation is characterized by the equipment including a direct release formulation, including amoxicillin and potassium bupropionate, and the optional conventional formulation (immediate release), including amoxicillin and slow release formulation Including amoxicillin (without potassium nail).
展开▼